Patent Advantage
StarBIA conducts and publishes research with universities, research institutes and hospitals in the field of body composition technologies, including bioelectrical impedance analysis from simple whole-body single-frequency mode to professional multi-segmental, multi-frequency mode. At this stage, StarBIA’s bioelectrical impedance analysis products are under Class II medical device applications of the Taiwan Food and Drug Administration (TFDA), the US Food and Drug Administration (USFDA), China Food and Drug Administration (CFDA) and the EU Medical Device Directive (MDD).
Corporate Philosophy
Vision: Be the first class and leading service provider in body composition
Purpose: Create new devices and services that benefit for human health and meet the health and medical needs of diverse populations.
Core Values: Practical research, Honesty, Public wellness, and Innovation
StarBIA obtains a patent certificate from China : Appearance design of body composition analyzer
StarBIA obtains a patent certificate from Taiwan : Method of Displaying Body Composition Data
StarBIA obtains the "Medical Device Manufacturers Permit"
StarBIA exhibits body composition analyzers at 2023 Medica Fair in Dusseldorf, Germany.
StarBIA wins the 20th National Innovation Award & Starup Award in Taiwan
StarBIA gets subsidy for 2023 Small Business Innovation Research from Taichung City Government, Taiwan.
StarBIA obtains ISO13485 Medical devices Quality management systems Certificate.
1.Method of Bioimpedance Technology To Evaluate Local or Whole Body Bone Mineral Density
2.Method of Bioimpedance Vector Analysis Technology To Evaluate Local or Whole Body Bone Mineral Density
Starbia201 Body Composition Analyzer for meddle-aged and elderly adults won the Application of Sports Technology Awards.
StartBIA moved into the Taichung Software Park.
StarBIA start to establish ISO13485 quality management system
StarBIA obtains a patent certificate entitled: "Data integration system for body composition analyzer"
Published literatures with the name of STARBIA
Bioimpedance analysis combined with sagittal abdominal diameter for abdominal subcutaneous fat measurement
Frontiers in Nutrition
Validation of Three Bioelectrical Impedance Analysis for the Assessment of Appendicular Lean Tissue, approved by Institutional Review Board (IRB)
StarBIA launched its flagship product, the Starbia701 Body Composition Analyzer
"Assessment of total and reginoal bone mineral density using bioelectrical impedance vector analysis in elderly population" was published on Scientific Reports
Regional and total body bone mineral density estimation using bioelectrical impedance analysis (Taiwan Intellectual Property Office, patent number I751050) and Method of bioimpedance vector analysis technology to evaluate local or wholebody bone mineral density (Taiwan Intellectual Property Office, patent number I751049)
StarBIA Meditek Co., Ltd. was officially established on June 4th, 2021
English 
中文